Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED‐HF study

AIMS: To test the prognostic value of emerging biomarkers in the Reduction of Events by Darbepoetin Alfa in Heart Failure (RED‐HF) trial. METHODS AND RESULTS: Circulating cardiac [N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP), and high‐sensitivity troponin T (hsTnT)], neurohumoral [mid‐regio...

Descripción completa

Detalles Bibliográficos
Autores principales: Welsh, Paul, Kou, Lei, Yu, Changhong, Anand, Inder, van Veldhuisen, Dirk J., Maggioni, Aldo P., Desai, Akshay S., Solomon, Scott D., Pfeffer, Marc A., Cheng, Sunfa, Gullestad, Lars, Aukrust, Pål, Ueland, Thor, Swedberg, Karl, Young, James B., Kattan, Michael W., Sattar, Naveed, McMurray, John J.V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2017
Materias:
Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607475/
https://www.ncbi.nlm.nih.gov/pubmed/28960777
http://dx.doi.org/10.1002/ejhf.988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607475/
https://www.ncbi.nlm.nih.gov/pubmed/28960777
http://dx.doi.org/10.1002/ejhf.988

Ejemplares similares